Certain Drugs Can Trigger or Slow Alzheimer’s Disease
|Good or Bad? Hmmm.|
Certain widely prescribed medications can trigger or slow the progress of Alzheimer’s disease, according to recently published research.
A Mount Sinai Medical Center team screened 1,600 FDA-approved medications, using a computer algorithm to determine which drugs are associated with blocking or stimulating beta amyloid accumulation. Amyloid plaques build up in the brains of Alzheimer’s patients.
Of the screened drugs, 800 reduced amyloid beta content more than 10% in primary neurons from mice, the researchers found. About 240 drugs promoted amyloid beta.
While many classes of drugs were found to impact amyloid beta production, the researchers focused especially on those used to treat cardiovascular conditions. Certain blood pressure medications, such as propranolol (Inderal) and nicardipine (Cardene), reduced amyloid beta production, while drugs including furosemide (Lasix) had the opposite effect. Experiments with mice confirmed that some CV medications, particularly carvedilol (Coreg), hold promise as Alzheimer’s drugs.
“This line of investigation will lead to the identification of common medications that are potentially beneficial or detrimental to [Alzheimer’s disease] as a reference for physicians to consider when prescribing the most appropriate drugs for their patients, particularly for treating chronic disorders among the growing geriatric population,” the researchers wrote.
Source: McKnight’s LTC
You may be interested
Care On The Road: How Telemedicine Can Reach Truck DriversLarry Alton - August 21, 2017
Telemedicine is considered a powerful tool for individuals living in rural areas, far from adequate services or in need of…
Where Is The Balance? Pushing Back Against Consumer Health TechLarry Alton - August 18, 2017
When Republican Congressman Jason Chaffetz glibly remarked that Americans struggling to afford insurance should choose between that and their smartphones,…